Latest News

Source: magnific.com  Ask ten UK traders which broker is best and you'll get a range of answers, because the "best" broker genuinely depends on how someone trades. But when you assess brokers against the criteria that matter most to the widest range of UK traders — regulation, track record, execution quality, platform choice and market [...]

Stock has declined 43% over the past year, though the CEO retains $27.8 million in direct holdings after the sale.

AbbVie's immunology franchise is firing on all cylinders while Bristol Myers Squibb navigates revenue declines and legal uncertainty.

Nvidia, Alphabet, and AMD have already bought most of the high bandwidth memory that will be manufactured next year.

Big things are in store for this rare-earth stock in one firm's estimation.

Mark Carney is courting global capital for Canada. Here's why Barrick Gold and Endeavour Mining look attractive to TSX investors right now.

Will rate hikes send the bull market crashing lower?

Choudary sold shares under a pre-scheduled trading plan adopted in April. The CFO retains 958,078 shares worth around $100 million.

Leach exercised 15,142 stock options at $3.99 per share under a pre-established Rule 10b5-1 trading plan, maintaining a direct stake of 823,886 shares worth $32.24 million.

With roughly 15 weeks until New Year's Eve, it's time to begin thinking about your next required minimum distribution.

Ryan Specialty, Kinsale Capital, and Casey's General Stores show strong asset-light, free-cash-flow-driven results, with revenue growth, margin gains, and analyst optimism supporting their outlooks.

You definitely do not want to toss it out or ignore it.

Apple began selling its latest premium smartphones Friday and analysts are cautiously optimistic about its prospects. Apple stock was flat.

Clover Health Investments (NASDAQ:CLOV) is positioning its Medicare Advantage business to benefit from industry pricing discipline, member retention and the maturation of member cohorts, Interim Chief Financial Officer Clay Thornton said at Jefferies’ Healthcare Services and Technology Conference in

Check out the companies making headlines this week: Sabre (NASDAQ:SABR): Travel technology company Sabre (NASDAQ:SABR) rose by 9.6% on Wednesday after the co...

Axsome is generating revenue from approved drugs but missing estimates and widening losses. Revolution Medicines just changed the standard of care for one of the deadliest cancers in existence.

We may not be in for a repeat of the last decade, but the odds of further gains are good.

This under-the-radar commerce software stock boasts a Superscore of 71 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

The names are not surprising. What is surprising, however, is just how big these companies have become, and how fast.

There's a moment a lot of growing brands hit where generic packaging just stops feeling right. The product's solid, the branding's coming together, and the

In the long run, the infrastructure powering the AI boom could become commoditized, with more of the value going to the businesses creating applications.

SK hynix and Intel are in early, unfinalized talks over U.S. memory chip production at Intel's Ohio site, a deal that boosted both stocks but lacks signed terms.

The ONT Price Trend remained firm during Q2 2026 as higher toluene feedstock costs increased the overall cost of producing Ortho Nitro Toluene (ONT). Geopo

Emergencies involving pets may appear unexpectedly. Sudden trauma, difficulty breathing, heavy blood loss, toxicosis, or sudden illness can require immedia

Commercial buildings need to support the activities that take place inside them. Offices, retail stores, restaurants, warehouses, medical facilities, and o